• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Interview: Veteran Shares How Ketamine Clinic Closings Hurt Patients

Jason Najum by Jason Najum
April 6, 2023
in Health & Wellness
Reading Time: 1 min read
A A
Interview: Veteran Shares How Ketamine Clinic Closings Hurt Patients

It’s been a bad time for ketamine therapy patients. First, the Biden administration announced the ending of Covid emergency measures around telemedicine. Then we had this recent run of clinic closings, with both KWC and Field Trip Health announcing closings.

But behind the headlines and falling stock prices, we are hearing how these changes are affecting patients

Purchase Certified Lasix Online

. These personal stories of mental health are the reason the entire industry is here in the first place – yet it’s something we tend to overlook.

Adam Blazak, a US Army veteran, was receiving ketamine treatments for mental health issues. The treatments were working – until Ketamine Wellness Centers suddenly closed operations and left him without treatment options.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

We sat down with Adam to discuss how veterans are being affected by these closures (and other limits to accessing psychedelic therapy).

Continue on your trip...

Bridging Psychedelics, Psychiatry, and Spirituality for Global Healing

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

See the full video below.

 

https://www.instagram.com/reel/CqqOGZrP8vq/?utm_source=ig_web_copy_link

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Ketamine
Jason Najum

Jason Najum

Jason Najum's work has appeared in many industry-leading publications, covering topics ranging from cleantech start-ups to travel and culture. He's currently Microdose's Managing Editor and Senior Writer. Write him at jason@microdose.buzz and see his work at www.jasonnajum.com

Next Post

Ketamine Wellness Centers Re-Opening? Delic Holdings Signs LOI with Peter/PetraMD

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.